AN IN-SILICO STUDY OF ANDALIMAN (Zanthoxylum acanthopodium DC.) AS AN ANTICANCER AGENT AGAINST TYROSINE KINASE ENZYME INHIBITION USING THE DOCKING METHOD: IN SILICO MOLECULAR DOCKING STUDY OF ACTIVE COMPOUNDS FROM ANDALIMAN (Zanthoxylum acanthopodium DC.) AGAINST TYROSINE KINASE ENZYME AS AN ANTICANCER AGENT. (2026). Forte Journal, 6(1), 348-372. https://doi.org/10.51771/fj.v6i1.2155